Scarica l'app Stockscreener
8.3299
6.29%
-0.4201
Precedente Chiudi:
$8.75
Aprire:
$8.4901
Volume 24 ore:
53,828
Relative Volume:
0.46
Capitalizzazione di mercato:
$55.78M
Reddito:
-
Utile/perdita netta:
$-75.08M
Rapporto P/E:
-0.7311
EPS:
-11.3931
Flusso di cassa netto:
$-40.10M
1 W Prestazione:
-7.55%
1M Prestazione:
+2.63%
6M Prestazione:
-65.98%
1 anno Prestazione:
-56.98%
Intervallo 1D:
$8.01
$8.6075
Intervallo di 1 settimana:
$8.01
$9.2713
Portata 52W:
$5.67
$42.79
Instil Bio Inc Stock (TIL) Company Profile
Nome
Instil Bio Inc
Settore
Industria
Telefono
(972) 499-3350
Indirizzo
3963 MAPLE AVENUE, DALLAS
Compare TIL vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
8.225 | 59.34M | 0 | -75.08M | -40.10M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.21 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.08 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
701.63 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.03 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.46 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2026-01-06 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-01-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-11-04 | Iniziato | JMP Securities | Mkt Perform |
| 2024-04-12 | Downgrade | Jefferies | Buy → Hold |
| 2022-11-01 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-11-01 | Downgrade | Truist | Buy → Hold |
| 2021-08-13 | Iniziato | Robert W. Baird | Outperform |
| 2021-04-13 | Iniziato | Cowen | Outperform |
| 2021-04-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-04-13 | Iniziato | Truist | Buy |
Mostra tutto
Instil Bio Inc Borsa (TIL) Ultime notizie
Precision Trading with Instil Bio Inc. (TIL) Risk Zones - Stock Traders Daily
TIL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Technical Reactions to TIL Trends in Macro Strategies - Stock Traders Daily
Instil Bio Inc expected to post a loss of $2.03 a shareEarnings Preview - TradingView
Does Instil Bio Inc. meet Warren Buffett’s criteriaEarnings Growth Report & Weekly Setup with ROI Potential - mfd.ru
Trading the Move, Not the Narrative: (TIL) Edition - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc.TIL - PR Newswire
Technical Analysis: Does Instil Bio Inc. meet Warren Buffett’s criteriaQuarterly Earnings Report & Growth Focused Investment Plans - mfd.ru
Market Leaders: Is Instil Bio Inc gaining market shareBreakout Watch & Advanced Technical Signal Analysis - baoquankhu1.vn
(TIL) Volatility Zones as Tactical Triggers - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, ... - Bluefield Daily Telegraph
TIL Should I Buy - Intellectia AI
Price-Driven Insight from (TIL) for Rule-Based Strategy - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (TIL) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Instil Bio, Inc. (TIL) And Encourages Shareholders to Connect - accessnewswire.com
Entry Recap: Is TROOPS Inc benefiting from interest rate changesJuly 2025 Opening Moves & Target Return Focused Stock Picks - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Instil Bio, Inc. (TIL) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
TIL ALERT: Ongoing Investigation Into Instil Bio, Inc.Contact Levi & Korsinsky - TMX Newsfile
Instil Bio Faces Investigation After AXN-2510 Discontinuation, Stock Plummets 45.81% - intellectia.ai
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (TIL) Stockholders to Inquire about Securities Investigation - accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Instil Bio, Inc. (TIL) and Encourages Investors to Learn More About the Investigation - accessnewswire.com
(TIL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Is Investigating Instil Bio, Inc. (TIL) And Encourages Investors to Connect - accessnewswire.com
Forecast Cut: Can Instil Bio Inc scale operations efficientlyJuly 2025 Closing Moves & Technical Buy Zone Confirmations - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AST SpaceMobile, Inc. - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Instil Bio, Inc. (TIL) And Encourages Stockholders to Reach Out - accessnewswire.com
Published on: 2026-01-13 02:54:06 - ulpravda.ru
Instil Bio, Inc. (TIL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Will Instil Bio Inc. stock see PE expansionJuly 2025 Drop Watch & Fast Entry Momentum Alerts - Улправда
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Instil Bio, Inc. (TIL) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Will Instil Bio Inc. stock benefit from green energy trendsMarket Risk Summary & Community Supported Trade Ideas - Улправда
Portfolio Update: Is Instil Bio Inc. stock a good choice for value investorsJuly 2025 Opening Moves & Daily Volume Surge Signals - Улправда
Citizens analyst reiterates Market Perform rating on Instil Bio stock By Investing.com - Investing.com South Africa
Why analysts remain bullish on Instil Bio Inc. stockMarket Entry Points & Low Risk Trading Portfolio - Улправда
Instil Bio (TIL) Downgraded to Neutral by HC Wainwright & Co. | TIL Stock News - GuruFocus
Instil On The Slide After PD-(L)1xVEGF Exit - Citeline News & Insights
Citizens analyst reiterates Market Perform rating on Instil Bio stock - Investing.com
Instil Bio ends license agreement with ImmuneOnco for AXN-2510 and AXN-27M - Investing.com Nigeria
Instil Bio Ends Key Oncology Licensing Agreement with ImmuneOnco - TipRanks
Instil Bio Terminates License and Collaboration Agreement With ImmuneOnco Biopharmaceuticals - TradingView — Track All Markets
Instil Bio shares slide on discontinuation of lead clinical programs - Proactive financial news
Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation By Investing.com - Investing.com South Africa
Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation - Investing.com Canada
Instil Bio Halts Main Drug Development Program - Bitget
US Stocks Mixed; Nasdaq Gains Over 50 Points - Benzinga
Instil's stock sinks after it clears out pipeline, hands 2 drugs back to ImmuneOnco - Fierce Biotech
Instil’s bispecific dream is over | ApexOncoClinical Trials news and analysis - Oncology Pipeline
Instil Bio stock falls after subsidiary discontinues AXN-2510 development By Investing.com - Investing.com Canada
Instil Bio stock falls after subsidiary discontinues AXN-2510 development - Investing.com
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco - The Manila Times
Instil Bio’s Subsidiary Discontinues Clinical Development - GlobeNewswire
Instil Bio Inc Azioni (TIL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.18%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):